Tersolisib

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameTersolisib
Drug Alias NameSTX-H1047-PI3KαPI3Kα Inhibitor (STX-478)STXH-1047ST814STX-478 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphoinositide 3-kinase alpha H1047X inhibitors
TargetsPhosphoinositide 3-kinase alpha H1047X
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesScorpion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSerán BioScience IncEli Lilly And CompanyScorpion Therapeutics Inc +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A